This breast cancer cell line was initially thought to be a monoclonal cell line but is now known as a population of breast cancer cells with high levels of molecular heterogeneity (but mostly ER+, estrogen-dependent, and SERMs-sensitive) 10, 11. This evidence concerns the gene ESR1 and breast carcinoma.